A detailed history of Toth Financial Advisory Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Toth Financial Advisory Corp holds 50,500 shares of CPRX stock, worth $1.07 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
50,500
Holding current value
$1.07 Million
% of portfolio
0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$15.19 - $21.35 $767,095 - $1.08 Million
50,500 New
50,500 $1 Million
Q1 2024

Apr 16, 2024

BUY
$13.18 - $17.11 $412,534 - $535,543
31,300 Added 1252.0%
33,800 $538,000
Q1 2023

Apr 24, 2023

BUY
$14.34 - $21.05 $28,680 - $42,100
2,000 Added 400.0%
2,500 $41,000
Q3 2022

Oct 14, 2022

BUY
$7.06 - $15.52 $3,530 - $7,760
500 New
500 $6,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.19B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.